Scientific poster presentations will be displayed in the Marketplace (free and open to the public) from Friday, April 21, through Sunday, April 23.
Conference: Poster Sessions
Fernanda Palhano-Fontes, M.D.
Comparing the Antidepressant Effects of Ayahuasca and Ketamine
Joseph Peter Barsuglia, Ph.D.
Characterization of Mystical Experiences Occasioned by 5-MeO-DMT-Containing Toad Venom and Comparison with Prior Psilocybin Studies
David Egert, Ph.D.
Physiological Correlates of Anxiety Associated with a Life-Threatening Illness in Subjects Undergoing MDMA-Assisted Psychotherapy
Chris Timmermann, Ph.D. (candidate)
Effects of DMT on the Human Brain as Measured by EEG
Anthony S. Gabay, M.Sc., Ph.D. (candidate)
MDMA Modulates Behaviour in the Prisoner's Dilemma and Ultimatum Game
Hayley Prescott, B.Sc.
Standardization of Banisteriopsis caapi: Towards an FDA-Approved Phase I Trial of B. caapi in Parkinson's Disease
Michiko Mitsunaga-Whitten, M.S.W. (candidate)
A Correlative Analysis of Mystical Experience and Treatment Outcomes from MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD
Nicolas Gravel, Ph.D. (candidate)
Spontaneous Hemodynamic Fluctuations Become Retinotopically Organized Under the Effect of LSD
Helen Harrison, B.A.
A Pilot Study of Oral Ketamine for Treatment-Resistant Depression
Joe Garand, M.A.
A Mixed-Methods Study of 2C-E's Potential for Self-Exploration and Healing
William Barone, Psy.D.
A Pilot Qualitative Investigation into the Experience and Views of Participants on Efficacy One Year Following a Study of MDMA-Assisted Psychotherapy for Adults with Treatment-Resistant PTSD
Ethan Hurwitz, B.S.
A Comparison of Psilocybin-Occasioned vs. Naturally-Occurring Experiences of Personal Encounters with the Divine
Henrique Fernandes Antunes Ph.D. (candidate)
Between Risks, Rights and Burdens: The Regulation Process of an Ayahuasca Church in the State of New Mexico
Jamie McAlpin and Christine Fitzsimmons, R.N., B.S.N.
Debunking Common Ibogaine Safety Myths
Crystal Hare, B.Sc.
The Use of MDMA-Assisted Psychotherapy to Treat Health-Related Anxiety in Patients with Chronic Medical Illness: A Pilot Study Proposal
Filip Tyls, M.D.
Dynamic Changes of Brain Networks Induced by Psilocybin: Multidimensional Approach to EEG Connectivity
Samuel Banister, Ph.D.
The Evolution of Synthetic Cannabinoid New Psychoactive Subtances
Juan Acosta-Urquidi, Ph.D.
EEG Studies of the Acute Effects of N,N and 5-MeO- DMT
Alan K. Davis, Ph.D.
Subjective Effectiveness of Ibogaine Treatment for Problematic Opioid Consumption: Short- and Long-Term Outcomes and Current Psychological Functioning
Tehseen Noorani, Ph.D.
Shifting the Impact of the Model Psychosis Theory: Emerging Entanglements Between Psychedelic Science and Post-Psychiatry
Kathryn Chilton, Medical Student
EEG Brain Dynamics and Altered States of Consciousness During Sub-Anesthetic Ketamine Dose Administration in Healthy Adults
Richard Idell, M.D.
Psilocybin for Treatment-Resistant Depression: From Bench to Bedside
Rosalind Watts, D.Clin.Psy.
Connected in the Deep: A Thematic Analysis of Follow-Up Reports from Patients Involved in a Clinical Trial of Psilocybin for Treatment-Resistant Depression
Benjamin J Malcolm, Pharm.D., M.P.H.
Changes in Withdrawal and Craving Scores in Subjects Undergoing Opioid Detoxification Utilizing Ibogaine
Ahnjili Zhuparris, M.Sc.
Pharmacological and Behavioral Interventions for Focus: The Comparison of Reversal Learning Under the Influence of Lysergic Acid Diethylmide (LSD), Methylphenidate (MPH), and Mindfulness
Selma Holden, M.D., M.P.H., M.S.
The Association of Psychedelic Use and Opioid Use Severity Among Illicit Users in the United States
Andrea Langlois, M.A.
Psychedelics, Entheogens, and Public Policy: Mapping a Path Forward
Rachel Harris, Ph.D.
Listening to Ayahuasca
Tanya Maté, N.D.
Ceremony and Dieta: Integration and Maximal Healing with Ayahuasca and Other Master Plants
Adam Snider, M.A., Psy.D. (candidate)
Addressing the Mental Health Needs of Clients Who Participate in Ayahuasca Ceremonies
Phillip Perl, B.S., M.P.H. (candidate)
A Pilot Qualitative Analysis of the Impact of Social Support in Long-Term Efficacy Following a Study of MDMA-Assisted Psychotherapy for Adults With Treatment-Resistant PTSD (Master's Thesis)
Julie D. Megler, M.S.N., N.P.-B.C.
A Dialogue Around the Therapeutic Uses of Ayahuasca for Trauma
Natalie L. Trent, Ph.D.
Subjective Effects of Salvia divinorum Use: A Retrospective Mixed Methods Approach
Steven Pennybaker, B.S.
Who is "Molly"? MDMA-Adulterants by Product Name and the Impact of Harm Reduction Services at "Raves"
Michelle S. Thiessen, B.A. (hons.), M.A. (candidate)
Psychedelic Use and Intimate Partner Violence: Emotion Regulation Mediates Protective Effects
Rita Kočárová, M.Sc.
Human Studies with Psychedelics and Delirogens in the Former Czechoslovakia: Implications for Future Research
Jan Ramaekers, Prof. Dr.
Psychedelics and Creativity
Paul Roberts, Ph.D.
Learning From the Plants: How Shipibo Healers Learn Their Craft
Nese Devenot, Ph.D.
The Role of Experimental Language in Psychedelic Science Research
Jerome Beck, Dr.P.H.
A Qualitative Follow-Up Study of MDMA-Assisted Psychotherapy for Veterans with Treatment-Resistant PTSD: Findings and Recommendations for Future Research
Mina Pas, M.D.
Evaluation of Healing Potential of Ayahuasca on Psychopathology and General Well-Being
Oriana Mayorga, B.S.
Knowledge of MDMA and Risk Propensity Relating to Perception of MDMA-Assisted Psychotherapy in Young Adults
Iker Puente, Ph.D.
A Comparison of the Subjective Effects of Different Psychedelics and Holotropic Breathwork Using the States of Consciousness Questionnaire (SCQ)
When Your Patient Takes Ayahuasca: What a Physician Should Know
Jennifer Lopes, Ph.D. (candidate)
Encounter with Brazilian Spirits: A Daimista Church in Quebec
Todd Y., Santo Daime Member
Sober Living: The Recovery House in a New Light
Ingmar Gorman, Ph.D. (candidate)
Psychotherapy Variables in MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
Joseph Tafur, M.D.
The Potential Role of Epigenetics in Ayahuasca Shamanism
Richard J. Zeifman, B.A.
Expanding Paradigms: The Case for Incorporating MDMA-assisted Psychotherapy Within Evidence-Based Treatments for Borderline Personality Disorder